These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19594731)

  • 1. Disease insight and treatment perception of men on active surveillance for early prostate cancer.
    van den Bergh RC; van Vugt HA; Korfage IJ; Steyerberg EW; Roobol MJ; Schröder FH; Essink-Bot ML
    BJU Int; 2010 Feb; 105(3):322-8. PubMed ID: 19594731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
    van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
    J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
    Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
    BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety and distress during active surveillance for early prostate cancer.
    van den Bergh RC; Essink-Bot ML; Roobol MJ; Wolters T; Schröder FH; Bangma CH; Steyerberg EW
    Cancer; 2009 Sep; 115(17):3868-78. PubMed ID: 19637245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
    Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ; Goldenberg SL
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
    Van Manen L; Feldman-Stewart D; Brundage MD
    Patient Educ Couns; 2006 Apr; 61(1):33-42. PubMed ID: 16257170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early outcomes of active surveillance for localized prostate cancer.
    Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
    BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ; Goldenberg SL; Gleave ME; Degner LF
    Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
    van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
    BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.
    van den Bergh RC; Vasarainen H; van der Poel HG; Vis-Maters JJ; Rietbergen JB; Pickles T; Cornel EB; Valdagni R; Jaspars JJ; van der Hoeven J; Staerman F; Oomens EH; Rannikko A; Roemeling S; Steyerberg EW; Roobol MJ; Schröder FH; Bangma CH
    BJU Int; 2010 Apr; 105(7):956-62. PubMed ID: 19817747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seeking help for erectile dysfunction after treatment for prostate cancer.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Arch Sex Behav; 2004 Oct; 33(5):443-54. PubMed ID: 15305115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.